CI

Cibus, Inc.

CBUS·NASDAQ

$1.40

-1.1%
HealthcareBiotechnology

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

At a Glance

Live Snapshot
Market Cap$63.68M
EPS-2.7800
P/E Ratio-0.50
Earnings Date08/06/2026

cbus

Total Liabilities

Last Annual Value

283.22M

3-Year CAGR

165%

5-Year CAGR

61%

10-Year CAGR

66%

CI

Cibus, Inc. Competitors Analysis of Total Liabilities

CBUS · NASDAQ
CompanyTotal Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
CBUS logo
Cibus, Inc.
NASDAQ:CBUS
283.22M
11.2%65.1%55.2% 
11.85M
-23.5%-12.4%N/A
CRVO logo
CervoMed Inc.
NASDAQ:CRVO
3.88M
14.3%5.8%-7.3%
44.59M
-11.1%11.0%N/A
1.35M
-75.9%-59.5%N/A
XBIT logo
XBiotech Inc.
NASDAQ:XBIT
9.73M
7.8%10.9%2.0%
25.38M
-1.6%-0.6%N/A
18.94M
1.7%53.0%N/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
4.02M
1.1%1.5%-2.7%
29.02M
-1.8%33.2%N/A
70.10M
-26.8%-26.3%-11.7%
CI

Cibus, Inc. Fair Value Envelope

CBUS · NASDAQ

Our analysis suggests that CBUS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.4, this represents a potential HIDDEN relative to our calculated worth for Cibus, Inc..

Intrinsic Value
Current Price: $1.4